Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

January 4, 2021

Study Completion Date

January 4, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

Dexcom G6 CGM System

continuous glucose monitor

DEVICE

Blood glucose meter

Blue-tooth enabled blood glucose meter

Trial Locations (15)

27517

University of North Carolina, Chapel Hill

28557

Carteret Medical Group, Morehead City

Lucas Research / Diabetes & Endocrinology Consultants, PC, Morehead City

30303

Emory University, Atlanta

37212

Vanderbilt Eskind Diabetes Clinic, Nashville

48105

University of Michigan Internal Medicine, Ann Arbor

48202

Henry Ford Medical Center, Detroit

50265

Iowa Diabetes and Endocrinology Research Center, West Des Moines

55416

Park Nicollet International Diabetes Center, Minneapolis

60611

Northwestern Memorial, Chicago

63130

Washington University Barnes Jewish Hospital, St Louis

79106

Amarillo Medical Specialists, LLP, Amarillo

89052

Las Vegas Endocrinology, Henderson

90022

Keck School of Medicine @ USC, Los Angeles

92121

Scripps Whittier Diabetes Institute, San Diego

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

DexCom, Inc.

INDUSTRY